HEALTHCARE

November 17, 2018

(AETOS Wire) -- SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc nucleus using its universal donor product, CybroCell™, today announced that a single injection of modified human dermal fibroblasts (HDFs), resulted in significant improvements of disc height and pain reduction 12 months after injection of the"... Continue Reading

November 15, 2018

The Ministry of Health (MoH) on Tuesday announced allocating 29 medical centers to provide round­the­clock services across the country and the Health Minister Sheikh Dr. Bassel Al­Sabah affirms readiness to any emergency.

The move is meant to deal with any emergency caused by volatile weather conditions and expected"... Continue Reading

November 15, 2018

• Establishes ResMed as a leader in out-of-hospital software-as-a-service offerings
• Expands ResMed’s SaaS offerings into additional care settings, including skilled nursing and senior living
• Purchase price $750 million, accretive to non-GAAP gross margin and non-GAAP diluted earnings per share

ResMed (NYSE: RMD) (ASX: RMD), a leader in cloud-connected medical"... Continue Reading

November 15, 2018

• Boehringer Ingelheim Expands Biomarker-driven Oncology Programs

• Alliance Enhances Epizyme’s Leadership in Oncology Epigenetics

Boehringer Ingelheim and Epizyme, Inc. (Nasdaq: EPZM) today announced a new global collaboration focused on the research, development and commercialization of novel small"... Continue Reading

November 15, 2018

Alliance Ventures, the strategic venture capital arm of Renault-Nissan-Mitsubishi, has announced today that it has invested in the latest round of funding in Enevate Corporation, an advanced lithium-ion (Li-ion) battery technology company based in Irvine, California. This marks the latest technology investment by Alliance Ventures, launched earlier this year to support start-ups, early-stage development,"... Continue Reading

November 15, 2018

HIMSS, a global advisor and thought leader supporting the transformation of health through information and technology, today announced the launch of regional editions of HealthcareITNews.com and MobiHealthNews.com for Asia Pacific, Europe and the United Kingdom. Both publications will combine regional news and analysis, with curated thought leadership and insights on the challenges facing the healthcare"... Continue Reading

November 15, 2018

A 100-bed capacity hospital opened in Cox’s Bazar district in Bangladesh. It is expected to serve 140,000 Rohingya refugees based in the Kutupalong camp.

This round-the-clock medical facility, built and managed by Médecins Sans Frontières (MSF) – Doctors without Borders with the support of Sharjah-based"... Continue Reading

November 14, 2018

KUWAIT CITY, Nov 13: Ministry of Health has affirmed that problems expatriates face with the health insurance services at Jabriya center will be solved soon with or without the involvement of the Health Insurance Company, reports Al- Seyassah daily.

Assistant Undersecretary for Legal Affairs of Ministry of Health Mohammad Al-Subai’e"... Continue Reading

November 14, 2018

(AETOS Wire) -- Further to the announcement on May 8, 2018, by Takeda Pharmaceutical Company Limited (“Takeda” or the “Company”) regarding the proposed acquisition (the “Acquisition”) of Shire plc (“Shire”), Takeda announces the publication of a circular (the “Circular”) containing a notice of its decision to"... Continue Reading

November 14, 2018

(AETOS Wire) -- Masimo (NASDAQ: MASI) announced today that a new consensus statement on postoperative anemia management was published in Anaesthesia by an international panel of clinicians specializing in patient blood management, which includes clear guidance on the use and benefits of noninvasive hemoglobin measurement.1 The statement, which discusses both spot-check and continuous measurement, references the Masimo Rad-67™ Pulse CO-Oximeter®, a spot-check device that measures noninvasive hemoglobin using Masimo SpHb®, as the example of noninvasive measurement. The statement notes in part that “The use of non-invasive continuous haemoglobin monitoring devices instead of phlebotomy may reduce blood loss, pain and discomfort for the patient, but concerns about precision limit routine clinical use. Although the debate focuses on accuracy...... Continue Reading